USPTO serial 79222493
SERONORM
Reviewed by CopyMark Law Group
Reg. 5567760Status 706Registered
- Filing date
- Status date
- Registration date
- Sep 25, 2018
- Examiner
- ESTRADA, LINDA M
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with SERONORM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kiranjit K Dharsan
Kiranjit K Dharsan Seiter IP1110 N Virgil Ave, Suite #98436Los Angeles, CA 90029United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biological preparations, reagents and chemical substances for scientific and research use and laboratory analysis, namely, for control of in vitro diagnostic (IVD) analysis results, other than for medical or veterinary purposes; chemical, biochemical and biological preparations for scientific and research use and laboratory analysis, namely, for control of calibration of in vitro diagnostic (IVD) analysis instruments, other than for medical, pharmaceutical or veterinary use; the before-mentioned goods excluding botanical extracts for use in the preparation of pharmaceutical products, cosmetics and foodstuff, and excluding pharmaceutical preparations for use in the treatment of infertility and/or ovulation induction, immunology, pediatrics and endocrinology, auto immune diseases, growth and metabolism, diseases of the central nervous system, cancer, viral diseases, and inflammatory disorders | ACTIVE | — |
| 005 | Medical diagnostic preparations used to control the results of medical analysis, namely, blood tests, that laboratories perform in order to diagnose and treat patients; the before-mentioned goods excluding pharmaceutical preparations for use in the treatment of infertility and/or ovulation induction, immunology, pediatrics and endocrinology, auto immune diseases, growth and metabolism, diseases of the central nervous system, cancer, viral diseases, and inflammatory disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 15, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 15, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 15, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 24, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 24, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 24, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 18, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 27, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 25, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 7, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 5, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 2, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 13, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 13, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 25, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 25, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 20, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 10, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 10, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 4, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 4, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 20, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 6, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 29, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 28, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 14, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 13, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 8, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |